V Edition of ChemoStart open
from September 2 to December 1, 2021
We look for innovative projects in health,submit your application HERE
ChemoStart is a global programme which provides support for startups and companies
designing innovative projects in the field of health and medical care.
NEW MEDICINES
WEARABLES
ARTIFICIAL INTELLIGENCE
DIAGNOSTICS METHODS
PRECISION MEDICINE
NEW APPLIED THECNOLOGIES
ChemoStart offers the winning startups a support programme which is tailored to their own specific needs. Each project is allocated a designated project manager to provide specific support on commercial processes, intellectual property, marketing and manufacturing, among other areas.
together, we will define the roadmap for your project to indetify the mentors who are best placed to meet your needs.
We´ll provide you with space at our offices so we can work side-by-side on your projet.
We´ll share our contact network with you to help grow your business and roll out pilot test.
We analyse startups and invest depending on the stage they are at (seed, early stage, series A)
Would you like a meeting with us? We provide training sessions and visits to our facilities so you can get a first-hand insight into how we work. Get in touch and get the full ChemoStart experience!
PITCH SESSION INVESTMENT SESSIONCOME AND MEET USINSUD PHARMA TOUR
Send us an email, we´ll be delighted to hear from you.
Marisa Abad
Manager – Beckman Coulter
Juan Alcántara
CEO de Nuubo
Felipe Blanco
Senior Advisor – Triton Partners
Juan Cruz Cigudosa
Science and Innovation Director & Founding Partner · NIMGenetics
Jaime Delgado Rodríguez
Consultant at Nowture
Adrià Escolá
Tech4Health Manager – Fundación Ship2B
Mario Grande Abascal
Managing Partner at Nowture
Antonio Herce
Investment Associate – Life Sciences at Inveready
Elena Hernando
Science and Innovation Director & Founding Partner · NIMGenetic
Robert Jenkins
CEO & Founder – Inxpyre Innovations Founder · Nuubo
Carlos R. Larrea
Business Development Manager – Innova-tsn
Agustín Maciá
CEO at Geroa Diagnostics & at Invezyme Research
Maite Malet
Investment Analyst – Asabys Partners
Raúl Martín-Ruiz
Partner – Ysios Capital
Guillem Masferrer
Investment Associate – Asabys Partners
María Poveda
Investment Associate – Life Sciences at Inveready
Enrique Samper
CEO & Founding Partner – NIMGenetics
Borja Smith
Partner at Bio-Innova
María Sola Gil
Director at Nowture
Michael Tadros
Project Manager – Fundación Botín
Beatriz Volckaert
Investment Analyst – Ship2B Ventures